References
- Abdel Ghafar MT. Aldosterone synthase gene (CYP11B2) polymorphisms and enhanced cardiovascular risk. In The recent topics in genetic polymorphisms (Eds. Çalişkan M, Erol O, Oz GC), IntechOpen Limited, London, 2019a.
- Abdel Ghafar MT. Association of aldosterone synthase CYP11B2 (−344C/T) gene polymorphism with essential hypertension and left ventricular hypertrophy in the Egyptian population. Clin Exp Hypertens 41, 779–786, 2019b.10.1080/10641963.2018.155767930561227
- Chai W, Hoedemaekers Y, van Schaik RH, van Fessem M, Garrelds IM, Saris JJ, Dooijes D, ten Cate FJ, Kofflard MM, Danser AH. Cardiac aldosterone in subjects with hypertrophic cardiomyopathy. J Renin Angiotensin Aldosterone Syst 7, 225–230, 2006.10.3317/jraas.2006.04217318792
- Chen JF, Jing J, Tan H, Song MB, Yu SY, Huang L. Lack of association of CYP11B2-344C/T polymorphism with essential hypertension: A meta-analysis. Int J Clin Exp Med 8, 9162–9167, 2015.
- Cheng X, Xu G. Association between aldosterone synthase CYP11B2 polymorphism and essential hypertension in Chinese: a meta-analysis. Kidney Blood Press Res 32, 128–140, 2009.10.1159/00021573819407459
- Connell JM, Fraser R, MacKenzie S, Davies E. Is altered adrenal steroid biosynthesis a key intermediate phenotype in hypertension? Hypertension 41, 993–999, 2003.10.1161/01.HYP.0000064344.00173.4412654713
- Connell JM, Davies E. The new biology of aldosterone. J Endocrinol 186, 1–20, 2005.10.1677/joe.1.0601716002531
- Dzhuryak V, Sydorchuk L, Sydorchuk A, Kamyshnyi O, Kshanovska A, Levytska S, Knut R, Sheremet M, Ivashchuk S, Petrynych O, Kazantseva T, Nikyfor L, Melnychuk L, Sokolenko A, Yarynych Y, Semianiv M, Repchuk Y, Voroniuk K, Sydorchuk R, Sokolenko L, Iftoda O, Kushnir O. The cytochrome 11B2 aldosterone synthase gene CYP11B2 (RS1799998) polymorphism associates with chronic kidney disease in hypertensive patients. Biointerface Research in Applied Chemistry 10, 5406–5411, 2020.
- Fernandes-Rosa FL, Williams TA, Riester A, Steichen O, Beuschlein F, Boulkroun S, Strom TM, Monticone S, Amar L, Meatchi T, Mantero F, Cicala MV, Quinkler M, Fallo F, Allolio B, Bernini G, Maccario M, Giacchetti G, Jeunemaitre X, Mulatero P, Reincke M, Zennaro MC. Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma. Hypertension 64, 354–361, 2014.10.1161/HYPERTENSIONAHA.114.0341924866132
- Freel EM, Connell JM. Mechanisms of hypertension: The expanding role of aldosterone. J Am Soc Nephrol 15, 1993–2001, 2004.10.1097/01.ASN.0000132473.50966.14128314215284285
- Ganapathipillai S, Laval G, Hoffmann IS, Castejon AM, Nicod J, Dick B, Frey FJ, Frey BM, Cubeddu LX, Ferrari P. CYP11B2-CYP11B1 haplotypes associated with decreased 11 beta-hydroxylase activity. J Clin Endocrinol Metab 90, 1220–1225, 2005.10.1210/jc.2004-103115507509
- Garg R, Adler GK. Aldosterone and the mineralocorticoid receptor: risk factors for cardiometabolic disorders. Curr Hypertens Rep 17, 52, 2015.10.1007/s11906-015-0567-826068659
- Hall JE, do Carmo JM, da Silva AA, Wang Z, Hall ME. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Circ Res 116, 991–1006, 2015.10.1161/CIRCRESAHA.116.305697436308725767285
- Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, Kusek JW, Manzi J, Van Lente F, Zhang YL, Coresh J, Levey AS; CKD-EPI Investigators. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 367, 20–29, 2012.10.1056/NEJMoa1114248439802322762315
- Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 150, 604–612, 2009.10.7326/0003-4819-150-9-200905050-00006276356419414839
- Leevin A, Stevens PE, Bilous RW, Coresh J, deFrancisco ALM, deJong P, Griffith KE, Hemmelgarn BR, Iseki K, Lamb EJ, et al. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Inter Suppl 3, 19–62, 2013.
- MacKenzie SM, Davies E, Alvarez-Madrazo S. Analysis of the aldosterone synthase (CYP11B2) and 11β-hydroxylase (CYP11B1) genes. Methods Mol Biol 1527, 139–150, 2017.10.1007/978-1-4939-6625-7_1128116713
- Nicod J, Bruhin D, Auer L, Vogt B, Frey FJ, Ferrari P. A biallelic gene polymorphism of CYP11B2 predicts increased aldosterone to renin ratio in selected hypertensive patients. J Clin Endocrinol Metab 88, 2495–2500, 2003.10.1210/jc.2002-02159812788845
- Schutten MT, Houben AJ, de Leeuw PW, Stehouwer CD. The link between adipose tissue renin-angiotensin-aldosterone system signaling and obesity-associated hypertension. Physiology (Bethesda) 32, 197–209, 2017.10.1152/physiol.00037.201628404736
- Sia SK, Chiou HL, Chen SC, Tsai CF, Yang SF, Ueng KC. Distribution and phenotypic expression of mineralocorticoid receptor and CYP11B2 T-344C polymorphisms in a Taiwanese hypertensive population. Mol Biol Rep 40, 3705–3711, 2013.10.1007/s11033-012-2446-623275203
- Stocco DM. StAR protein and the regulation of steroid hormone biosynthesis. Annu Rev Physiol 63, 193–213, 2001.10.1146/annurev.physiol.63.1.19311181954
- Sydorchuk LP, Sokolenko AA, Sydorchuk AR, Kryklyvets LG, Biryuk IG, Fliundra IG, Sokolenko MA. Insulin resistance in patients with arterial hypertension and abdominal obesity depending on ace and ppar-γ2 genes polymorphism: A new opinion concerning an old problem. New Armenian Medical Journal 9, 43–51, 2015a.
- Sydorchuk LP, Ursuliak YV. Genes allele status of angiotensinconverting enzyme (I/D) and endothelial nitric oxide synthase (894 G > T) in patients with acute coronary syndrome. Likarska sprava/Ministerstvo okhorony zdorovia Ukrainy (Ukraine) 5–6, 24–34, 2015b.
- Sydorchuk LP, Serdulets YI, Fediv OI, Havrysh LO, Teleki YM, Sydorchuk AR, Kshanovska AI, Turubarova-Leunova NA, Lekhai DO. The polymorphism of matrilin-3 (rs77245812) and interleukin-10 (rs1800872) genes in osteoarthritis patients with arterial hypertension, obesity and type 2 diabetes mellitus. Arch Balk Med Union 52, 422–429, 2017.10.24061/2413-0737.XXII.1.85.2018.18
- Tomaschitz A, Pilz S, Ritz E, Obermayer-Pietsch B, Pieber TR. Aldosterone and arterial hypertension. Nat Rev Endocrinol 6, 83–93, 2010.10.1038/nrendo.2009.26320027193
- Tsujita Y, Iwai N, Katsuya T, Higaki J, Ogihara T, Tamaki S, Kinoshita M, Mannami T, Ogata J, Baba S. Lack of association between genetic polymorphism of CYP11B2 and hypertension in Japanese: the Suita study. Hyper-tens Res 24, 105–109, 2001.10.1291/hypres.24.10511325068
- Tsybouleva N, Zhang L, Chen S, Patel R, Lutucuta S, Nemoto S, DeFreitas G, Entman M, Carabello BA, Roberts R, Marian AJ. Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy. Circulation 109, 1284–1291, 2004.10.1161/01.CIR.0000121426.43044.2B277953314993121
- Whaley-Connell A, Johnson MS, Sowers JR. Aldosterone: role in the cardiometabolic syndrome and resistant hyper-tension. Prog Cardiovasc Dis 52, 401–409, 2010.10.1016/j.pcad.2009.12.004284105720226958
- Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I, Authors/Task Force Members. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension [published correction appears in J Hypertens 37, 226, 2019]. J Hypertens 36, 1953–2041, 2018.
- Ye WJ, Zheng L, Wang ZH, Chen HH. [Meta analysis on the association of CYP11B2 gene polymorphism and essential hypertension in Chinese Han population.] Zhonghua Xin Xue Guan Bing Za Zhi 41, 795–799, 2013.